Peter G. Traber, President & CEO at GALECTIN THERAPEUTICS INC (GALT), bought 4,000 shares at $2.53 ($10K) on 2015-06-01, disclosed to the SEC on 2015-06-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| SELB | SELL | 2022-01-07 | $10K | — | Filing → |
| SELB | SELL | 2021-12-14 | $12K | — | Filing → |
| SELB | SELL | 2021-10-15 | $16K | — | Filing → |